These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28678394)

  • 1. Risk of persistent or recurrent cervical neoplasia in patients with 'pure' adenocarcinoma-in-situ (AIS) or mixed AIS and high-grade cervical squamous neoplasia (cervical intra-epithelial neoplasia grades 2 and 3 (CIN 2/3)): a population-based study.
    Codde E; Munro A; Stewart C; Spilsbury K; Bowen S; Codde J; Steel N; Leung Y; Tan J; Salfinger SG; Mohan GR; Cohen PA
    BJOG; 2018 Jan; 125(1):74-79. PubMed ID: 28678394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of persistent and recurrent cervical neoplasia following incidentally detected adenocarcinoma in situ.
    Munro A; Codde J; Spilsbury K; Steel N; Stewart CJ; Salfinger SG; Tan J; Mohan GR; Leung Y; Semmens JB; O'Leary P; Williams V; Cohen PA
    Am J Obstet Gynecol; 2017 Mar; 216(3):272.e1-272.e7. PubMed ID: 27908632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of persistent or recurrent neoplasia in conservatively treated women with cervical adenocarcinoma in situ with negative histological margins.
    Munro A; Codde J; Spilsbury K; Stewart CJ; Steel N; Leung Y; Tan J; Salfinger SG; Mohan GR; Semmens JB; Cohen PA
    Acta Obstet Gynecol Scand; 2017 Apr; 96(4):432-437. PubMed ID: 28181670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Recurrence After Treatment for Cervical Intraepithelial Neoplasia 3 and Adenocarcinoma In Situ of the Cervix: Recurrence of CIN 3 and AIS of Cervix.
    Swift BE; Wang L; Jembere N; Kupets R
    J Low Genit Tract Dis; 2020 Jul; 24(3):252-258. PubMed ID: 32384365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incomplete excision of cervical intraepithelial neoplasia as a predictor of the risk of recurrent disease-a 16-year follow-up study.
    Alder S; Megyessi D; Sundström K; Östensson E; Mints M; Belkić K; Arbyn M; Andersson S
    Am J Obstet Gynecol; 2020 Feb; 222(2):172.e1-172.e12. PubMed ID: 31473226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk stratified management of cervical adenocarcinoma in situ based on cone margin state].
    Huang SS; Sui L; Chen LM; Zhang HW; Tao X
    Zhonghua Fu Chan Ke Za Zhi; 2021 Sep; 56(9):622-629. PubMed ID: 34547863
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk of high-grade cervical dysplasia and gynaecological malignancies following the cytologic diagnosis of atypical endocervical cells of undetermined significance: a retrospective study of a state-wide screening population in Western Australia.
    Munro A; Williams V; Semmens J; Leung Y; Stewart CJ; Codde J; Spilsbury K; Steel N; Cohen P; O'leary P
    Aust N Z J Obstet Gynaecol; 2015 Jun; 55(3):268-73. PubMed ID: 26044565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excisional treatment in women with cervical adenocarcinoma in situ (AIS): a prospective randomised controlled non-inferiority trial to compare AIS persistence/recurrence after loop electrosurgical excision procedure with cold knife cone biopsy: protocol for a pilot study.
    Cohen PA; Brand A; Sykes P; Wrede DCH; McNally O; Eva L; Rao A; Campion M; Stockler M; Powell A; Codde J; Bulsara MK; Anderson L; Leung Y; Farrell L; Stoyles P
    BMJ Open; 2017 Aug; 7(8):e017576. PubMed ID: 28851799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term predictors of residual or recurrent cervical intraepithelial neoplasia 2-3 after treatment with a large loop excision of the transformation zone: a retrospective study.
    Fernández-Montolí ME; Tous S; Medina G; Castellarnau M; García-Tejedor A; de Sanjosé S
    BJOG; 2020 Feb; 127(3):377-387. PubMed ID: 31631477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of endocervical margin and high-risk human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia, adenocarcinoma in situ, and microinvasive carcinoma of the uterine cervix.
    Kong TW; Son JH; Chang SJ; Paek J; Lee Y; Ryu HS
    Gynecol Oncol; 2014 Dec; 135(3):468-73. PubMed ID: 25284039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing persistence or recurrence of cervical intraepithelial neoplasia after loop electrosurgical excision procedure.
    Malapati R; Chaparala S; Cejtin HE
    J Low Genit Tract Dis; 2011 Jul; 15(3):177-9. PubMed ID: 21716049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting outcome after incomplete excision of cervical intraepithelial neoplasia.
    Paraskevaidis E; Kalantaridou SN; Paschopoulos M; Zikopoulos K; Diakomanolis E; Dalkalitsis N; Makrydimas G; Pappa L; Malamou-Mitsi V; Agnantis NJ
    Eur J Gynaecol Oncol; 2003; 24(6):541-3. PubMed ID: 14658599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical Screening Results Leading to Detection of Adenocarcinoma in Situ of the Uterine Cervix.
    Srisomboon S; Tantipalakorn C; Charoenkwan K; Srisomboon J
    Asian Pac J Cancer Prev; 2019 Feb; 20(2):377-382. PubMed ID: 30803195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocervical adenocarcinoma in situ-from Papanicolaou test to hysterectomy: a series of 74 cases.
    Lashmanova N; Braun A; Cheng L; Gattuso P; Yan L
    J Am Soc Cytopathol; 2022; 11(1):13-20. PubMed ID: 34509373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management and long-term outcomes of women with adenocarcinoma in situ of the cervix: A retrospective study.
    Tan JHJ; Malloy MJ; Thangamani R; Gertig D; Drennan KT; Wrede CD; Saville M; Quinn M
    Aust N Z J Obstet Gynaecol; 2020 Feb; 60(1):123-129. PubMed ID: 31578727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for residual disease after cervical conization in patients with cervical intraepithelial neoplasia grades 2 and 3 and positive surgical margins.
    Ayhan A; Tuncer HA; Reyhan NH; Kuscu E; Dursun P
    Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():1-6. PubMed ID: 27038228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the safety between cervical conization and hysterectomy for patients with cervical adenocarcinoma in situ.
    Liu J; Wang Y; Wan X; Zou J; Zhu Y; Lv W; Shen Y
    J Gynecol Oncol; 2023 Jan; 34(1):e8. PubMed ID: 36424703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical intraepithelial neoplasia and the risk of spontaneous preterm birth: A Dutch population-based cohort study with 45,259 pregnancy outcomes.
    Loopik DL; van Drongelen J; Bekkers RLM; Voorham QJM; Melchers WJG; Massuger LFAG; van Kemenade FJ; Siebers AG
    PLoS Med; 2021 Jun; 18(6):e1003665. PubMed ID: 34086680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of a loop electrosurgical excision procedure for cervical intraepithelial neoplasia in a high incidence country.
    Sangkarat S; Ruengkhachorn I; Benjapibal M; Laiwejpithaya S; Wongthiraporn W; Rattanachaiyanont M
    Asian Pac J Cancer Prev; 2014; 15(2):1035-9. PubMed ID: 24568447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome after conization for cervical intraepithelial neoplasia grade III: relation with surgical margins, extension to the crypts and mitoses.
    Maluf PJ; Adad SJ; Murta EF
    Tumori; 2004; 90(5):473-7. PubMed ID: 15656332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.